MolNFT v1 · #68556 · protein
Human mdmx liganded with a 12MER peptide inhibitor (pdiq)
3JZQ · Protein MDM4: “Human mdmx liganded with a 12MER peptide inhibitor (pdiq)”. X-ray diffraction, 1 ligand (SO4), 2 pockets (best druggability 0.43). MolNFT v1 #68556 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 3JZQ
- Type
- protein
- Length
- 195 residues
- Chains
- 4
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Protein MDM4; Pdiq peptide (12MER)
- UniProt
- O15151
- Ligands
- SO4
- Pockets
- 2 · best druggability 0.43
Structure
x-ray diffraction · 3 distinct chains · 46% helix, 16% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Protein MDM4 | protein | 84 | 46% helix, 15% strand | O15151 |
| P, Q | Pdiq peptide (12MER) | protein | 12 | 50% helix, 0% strand | — |
| B | Protein MDM4 | protein | 87 | 46% helix, 20% strand | O15151 |
Ligands and binding sites
- SO4 · Sulfate ion · ion · chains B, Q
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 112 | 0.43 | 0.77 | 23 | empty |
| 2 | 55 | 0.28 | 0.74 | 12 | empty |
Interfaces
3 interfaces between chains.
- A–P · 574 Ų buried · 4 hydrogen bonds · protein-protein
- B–Q · 564 Ų buried · 5 hydrogen bonds · protein-protein
- A–B · 459 Ų buried · 4 hydrogen bonds · protein-protein
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt O15151
- Elsewhere: RCSB PDB 3JZQ · PDBe 3JZQ · UniProt O15151
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.